What is the Return on Assets (ROA) of SI-BONE this year?
The Return on Assets (ROA) of SI-BONE is -0.19 undefined this year.
SI-BONE ROA 2024
SI-BONE ROA
-0.19
Ticker
SIBN
ISIN
US8257041090
WKN
A2N7LY
In 2024, SI-BONE's return on assets (ROA) was -0.19, a -51.65% increase from the -0.39 ROA in the previous year.
SI-BONE Aktienanalyse
What does SI-BONE do?
SI-BONE Inc. is an innovative medical technology company based in Santa Clara, California. It was founded in 2008 by a group of orthopedic surgeons, engineers, and entrepreneurs who aimed to improve the treatment of lower back pain. The company is now globally recognized and specializes in the development and marketing of implants for the treatment of pain and discomfort in the pelvic and back areas. SI-BONE focuses on the treatment of pain and discomfort in the pelvic and back areas, offering a range of products for this purpose. The company's main focus is on the development of innovative implants that can be used minimally invasively, with the goal of providing patients with quick recovery and improved quality of life. The flagship product of SI-BONE is the iFuse implant. This implant is used in patients with chronic lower back pain caused by instability of the spine or pelvis. The iFuse implant stabilizes the pelvis and thereby reduces the pain originating from the unstable joint region. The iFuse implant has been FDA approved and is now available in over 40 countries worldwide. In addition to the iFuse implant, SI-BONE also offers a variety of other products tailored to the needs of physicians and patients. These include implantable instruments and consumables such as bone screws or arthroscopy needles. SI-BONE is a publicly traded company listed on NASDAQ under the ticker symbol "SIBN." The company's business model is based on providing innovative products to physicians and hospitals that optimize the treatment of back pain. To achieve this, SI-BONE works closely with leading industry professionals to enable optimal treatment of back pain. SI-BONE has established itself as a strong, innovative company specializing in minimally invasive implants in the field of pain therapy. Through close collaboration with physicians and specialists and investment in research and development of cutting-edge technologies, SI-BONE aims to continue growing and achieve a leading position in the field of pain therapy. SI-BONE ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding SI-BONE's Return on Assets (ROA)
SI-BONE's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing SI-BONE's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider SI-BONE's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in SI-BONE’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about SI-BONE stock
What was the ROA of SI-BONE compared to the previous year?
The ROA of SI-BONE has increased by -51.65% compared to the previous year.
What consequences do high ROA have for investors of SI-BONE?
A high ROA is advantageous for investors of SI-BONE, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in SI-BONE?
A low ROA can be unfavorable for investors of SI-BONE as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of SI-BONE affect the company?
An increase in ROA of SI-BONE can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of SI-BONE impact the company?
A reduction in the ROA of SI-BONE can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of SI-BONE?
Some factors that can influence the ROA of SI-BONE include revenue, operating costs, asset structure, and industry average.
Why is the ROA of SI-BONE important for investors?
The ROA of SI-BONE is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can SI-BONE take to improve ROA?
To improve ROA, SI-BONE can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does SI-BONE pay?
Over the past 12 months, SI-BONE paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, SI-BONE is expected to pay a dividend of 0 USD.
What is the dividend yield of SI-BONE?
The current dividend yield of SI-BONE is .
When does SI-BONE pay dividends?
SI-BONE pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of SI-BONE?
SI-BONE paid dividends every year for the past 0 years.
What is the dividend of SI-BONE?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is SI-BONE located?
SI-BONE is assigned to the 'Health' sector.
Wann musste ich die Aktien von SI-BONE kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of SI-BONE from 7/16/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/16/2024.
When did SI-BONE pay the last dividend?
The last dividend was paid out on 7/16/2024.
What was the dividend of SI-BONE in the year 2023?
In the year 2023, SI-BONE distributed 0 USD as dividends.
In which currency does SI-BONE pay out the dividend?
The dividends of SI-BONE are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The SI-BONE stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von SI-BONE
Our stock analysis for SI-BONE Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of SI-BONE Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
